Triptorelin
Triptorelin is a licensed medicine with phase III oncology evidence, randomized dose-escalation research, and pooled paediatric data in central...
About:
A GnRH agonist approved for prostate cancer, endometriosis and central precocious puberty.
What does this peptide do?
Supported by randomised human trials. Research focuses on prostate cancer, endometriosis and precocious puberty.
Prostate cancer
A GnRH agonist approved for prostate cancer.
Endometriosis
Also approved for endometriosis.
Precocious puberty
Also approved for central precocious puberty.
Evidence grade
AHighest evidence grade among the graded claims: A. Grades reflect study strength, not benefit.
What are the benefits and side effects of this peptide
What research says it may help with
- Triptorelin is a licensed medicine with phase III oncology evidence, randomized dose-escalation research, and pooled paediatric data in central precocious puberty.
Who should avoid it
- People who are pregnant or breastfeeding
- Children and adolescents
- Anyone using it outside clinical supervision, given profound hormonal suppression
- Pregnancy
- Known hypersensitivity to GnRH analogues
See the safety section. Absence of a flag is not evidence of safety.
A grade reflects evidence strength, not a recommendation to use this compound; a strong grade can attach to a harmful effect.
How to store this peptide
Supplied as a depot injection administered by a clinician in licensed use.
Lyophilized storage
Refrigerate at 2–8 °C in the original carton. Do not freeze.
Reconstituted storage
Once in use, may be kept below 30 °C for the period stated on the product label.
Storage Handling
Protect from light. Do not use if it has been frozen.
Related research
Related research is coming soon for this peptide.
Related peptides
WellnessPT-141
Bremelanotide, studied for libido and sexual-wellness research.
WellnessDSIP
DSIP was isolated from work on sleep transmission in rabbits in the 1970s, and that origin is well documented. Its sleep effects rest on old...
WellnessThymosin Alpha-1
Thymosin alpha-1 is among the better studied compounds here: randomized trials cover severe sepsis, chronic hepatitis and adjuvant cancer...